Chapter 1: The COVID-19 Pandemic and Its Unfolding

As the world gradually recovers from the dire impacts of the COVID-19 pandemic, especially after a challenging spring in 2021, some regions are witnessing a decrease in cases. Those countries that have efficiently rolled out vaccinations are experiencing a notable decline in infections, while others continue to grapple with the virus that has affected over 176 million individuals and led to more than 3.8 million deaths. So far, approximately 2.4 billion vaccine doses have been administered globally.

Recently, Novavax, a lesser-known American biotech firm supported significantly by the U.S. government, reported promising results from its Phase 3 clinical trial, indicating an impressive overall efficacy rate of 90.4%. This effectiveness aligns closely with that of the Pfizer-BioNTech and Moderna vaccines and surpasses that of the single-dose Johnson & Johnson vaccine. Notably, the Novavax vaccine demonstrated a 100% efficacy rate in preventing moderate to severe cases of the disease.

After over a year of research, we have made strides in understanding the varied responses to COVID-19. Notably puzzling to scientists has been the phenomenon of asymptomatic infections, where certain individuals do not exhibit any symptoms despite being infected.

Researchers from Newcastle University in the UK may have uncovered a breakthrough in this area. Their study, funded by Innovate UK, compared asymptomatic individuals with those from the same community who experienced severe COVID-19 without any underlying health issues.

“This is a significant discovery as it may shed light on why some individuals contract COVID but remain healthy. It could pave the way for genetic testing that helps identify those who should be prioritized for vaccinations in the future.”

~ Dr. Carlos Echevarria, Co-Author of the Study

The research team found that the gene HLA-DRB1*04:01 appeared three times more frequently in asymptomatic individuals, suggesting it may confer some level of defense against severe illness from COVID-19. This discovery marks the first substantial evidence of genetic resistance playing a vital role in preventing illness or symptoms.

To conduct the study, researchers compared patients who had severe COVID-19 with an asymptomatic group, employing next-generation sequencing to thoroughly examine the HLA genes located on chromosome 6. Previous genome scans have proven less effective than this targeted approach.

Genome-wide examinations of the HLA-DRB1*04:01 gene revealed a correlation with geographic location — individuals in Northern and Western Europe are more likely to possess this gene. Essentially, populations of European descent may be more likely to remain asymptomatic while still capable of transmitting the virus to those who are more susceptible.

It's a well-established idea in science that specific genetic traits can relate to geographical distribution, with HLA genes evolving over generations in response to disease-causing pathogens. The sample for the trials included 49 patients who had been hospitalized due to severe COVID-19 and 69 asymptomatic hospital workers who tested positive via routine antibody screening, alongside a control group.

Researchers utilized next-generation sequencing technology to analyze the various versions, or alleles, of the HLA genes in detail, combining diverse expertise and modeling techniques. The sample population was drawn exclusively from North East England during the initial lockdown.

Further studies in different populations will be necessary to confirm these findings, as varying copies of HLA genes could provide resistance in other groups. Nevertheless, this research offers a valuable starting point in unraveling one of the pandemic's most significant mysteries.

Complete Research was published in the Journal of HLA.

Chapter 2: Understanding Asymptomatic COVID-19 Cases

The first video titled "Asymptomatic with COVID? You can probably thank your genes" delves into how genetic factors may contribute to asymptomatic cases of COVID-19. It explores the implications of this research and its potential impact on public health strategies.

The second video, "Let Me Explain: Asymptomatic COVID Genes | NBCLA," provides a detailed explanation of the genetic mechanisms at play in asymptomatic COVID-19 cases, highlighting the importance of continued research in this area.

Stay updated with the latest information that matters — Join my mailing list.